Enhancing Immunotherapy in Glioblastoma: New Hope Through Electric Field Therapy

Key Findings: ​In a recent study published in Cell Medicine, researchers explored the potential of combining electric field therapy with the immunotherapy drug pembrolizumab to improve treatment outcomes for patients with glioblastoma—an aggressive and treatment-resistant form of brain cancer. The study found that patients who received both electric field therapy and pembrolizumab experienced a significantly […]

Enhancing Immunotherapy in Glioblastoma: New Hope Through Electric Field Therapy Read More »